Nanjing Leads Biolabs Co., Ltd. (HKG:9887)
Hong Kong · Delayed Price · Currency is HKD 76.10
+5.65 (8.02%)
Aug 20, 2026, 4:09 PM HKT
Nanjing Leads Biolabs Market Cap
Nanjing Leads Biolabs has a market cap or net worth of 15.14 billion as of August 20, 2026. Its market cap has increased by 3.61% in one year.
Market Cap
15.14B
Enterprise Value
13.73B
Revenue
197.25M
Ranking
n/a
PE Ratio
n/a
Stock Price
76.10
ChartMarket Cap Chart
Since July 25, 2025, Nanjing Leads Biolabs's market cap has increased from 12.97B to 15.14B, an increase of 16.66%. That is a compound annual growth rate of 15.47%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 20, 2026 | 15.14B | 49.22% |
| Dec 31, 2025 | 10.14B | -21.82% |
| Jul 25, 2025 | 12.97B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Keymed Biosciences | 22.70B |
| Duality Biotherapeutics | 16.42B |
| Metis TechBio | 13.86B |
| Ascentage Pharma Group International | 12.79B |
| HBM Holdings | 12.57B |
| GenFleet Therapeutics (Shanghai) | 11.04B |
| Ascletis Pharma | 10.38B |
| Shaanxi Micot Pharmaceutical Technology | 10.15B |